<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 21 Jul 2026 06:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Mach42 Completes £7M Funding Round, Led by IP Group With Investment From BGF and Foresight Group</title>
   <link>http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;
Funding to accelerate agentic-ready simulation&lt;b&gt; &lt;/b&gt;to enable semiconductor engineers to verify complex analog circuits with 100x verification coverage

&lt;/p&gt;
&lt;p&gt;    SANTA CLARA, Calif. &amp;amp; OXFORD, England--(BUSINESS WIRE)--
Mach42, an AI-driven company developing technology to accelerate analog circuit simulation for semiconductor design, has closed a £7m pre-series A funding round.

&lt;/p&gt;&lt;p&gt;
The round was led by IP Group plc, the most active UK based-early-stage science and technology investor, alongside existing investors BGF and Foresight Group. The funding will enable Mach42 to scale its engineering and business development teams and accelerate commercial adoption.

&lt;/p&gt;&lt;p&gt;
Demand for ever more powerful and efficient chips is increasing the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Mach42+Completes+%C2%A37M+Funding+Round%2C+Led+by+IP+Group+With+Investment+From+BGF+and+Foresight+Group/26791359.html</guid>
   <pubDate>Tue, 21 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.29951737</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50200257</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00715304</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.03175770</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10314897</category>
   	  </item>
  <item>
   <title>Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer</title>
   <link>http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</link>
   <description>&lt;p&gt;Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer&lt;/p&gt;&lt;p&gt; &lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</guid>
   <pubDate>Mon, 08 Dec 2025 15:18:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NTR</category>
   	  </item>
  <item>
   <title>Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer</title>
   <link>http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</link>
   <description>&lt;p&gt;Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer&lt;/p&gt;&lt;p&gt; &lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</guid>
   <pubDate>Mon, 08 Dec 2025 15:18:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NTR</category>
   	  </item>
  <item>
   <title>Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer</title>
   <link>http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</link>
   <description>&lt;p&gt;Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer&lt;/p&gt;&lt;p&gt; &lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</guid>
   <pubDate>Mon, 08 Dec 2025 15:18:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NTR</category>
   	  </item>
  <item>
   <title>Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer</title>
   <link>http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</link>
   <description>&lt;p&gt;Trump Threatens 'Severe' Tariffs On Canada Over Fertilizer&lt;/p&gt;&lt;p&gt; &lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Trader+Talk/Trump+Threatens+%27Severe%27+Tariffs+On+Canada+Over+Fertilizer/25711978.html</guid>
   <pubDate>Mon, 08 Dec 2025 15:18:46 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MOS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NTR</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
  <item>
   <title>Frazier Life Sciences Appoints Aditya Kohli to Partner</title>
   <link>http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</link>
   <description>
&lt;p&gt;    PALO ALTO, Calif.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Ffrazierls.com%2F&amp;amp;esheet=54239276&amp;amp;newsitemid=20250417404312&amp;amp;lan=en-US&amp;amp;anchor=Frazier+Life+Sciences&amp;amp;index=1&amp;amp;md5=b2453c86cda000c0912cbd4dd12088e9&quot; shape=&quot;rect&quot;&gt;Frazier Life Sciences&lt;/a&gt; (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Aditya Kohli, Ph.D., to Partner.
&lt;/p&gt;&lt;p&gt;
Since joining FLS in 2016, Dr. Kohli has played a foundational role in company creation, co-founding six life sciences companies, including HilleVax (NASDAQ: HLVX, IPO in 2022), Phathom Pharmaceuticals (NASDAQ: PHAT, IPO in 2019), and Scout Bio (acquired by Ceva Santé Animale). He previously acted as Chief Business Officer at Phathom, Chief Operating Officer at HilleVax, and served on the Board of Scout Bio. He currently serves on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Frazier+Life+Sciences+Appoints+Aditya+Kohli+to+Partner/24651082.html</guid>
   <pubDate>Thu, 17 Apr 2025 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">2019</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">2022</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03350906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.27822871</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012012</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HLVX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">IPO</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.01868273</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04698756</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.35145684</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.46101405</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54217040</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PHAT</category>
   	  </item>
 </channel>
</rss>
